2,4-Dimethylphenyl-4-(2-Oxo-3-propylimidazolidin-1-yl)benzenesulfonate

ID: ALA4098110

PubChem CID: 89251679

Max Phase: Preclinical

Molecular Formula: C20H24N2O4S

Molecular Weight: 388.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCN1CCN(c2ccc(S(=O)(=O)Oc3ccc(C)cc3C)cc2)C1=O

Standard InChI:  InChI=1S/C20H24N2O4S/c1-4-11-21-12-13-22(20(21)23)17-6-8-18(9-7-17)27(24,25)26-19-10-5-15(2)14-16(19)3/h5-10,14H,4,11-13H2,1-3H3

Standard InChI Key:  OOVSCZBSVGQNJE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    8.1430   -5.5140    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5557   -6.2239    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.9642   -5.5115    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4371   -6.6407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4359   -7.4602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1440   -7.8692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8536   -7.4597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8508   -6.6371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1422   -6.2318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2684   -6.6262    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9876   -6.2382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6800   -6.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3987   -6.2804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4227   -5.4626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7221   -5.0338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0063   -5.4236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7279   -7.8682    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9843   -7.5386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4370   -8.1454    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8451   -8.8535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6445   -8.6841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8141   -6.7393    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6244   -8.0594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1435   -8.7201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3309   -8.6341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6552   -7.4845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1414   -5.0736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8  2  1  0
  2 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  5 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 17  1  0
 18 22  2  0
 19 23  1  0
 23 24  1  0
 24 25  1  0
 12 26  1  0
 14 27  1  0
M  END

Associated Targets(Human)

M21 (1715 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 388.49Molecular Weight (Monoisotopic): 388.1457AlogP: 3.72#Rotatable Bonds: 6
Polar Surface Area: 66.92Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.14CX LogD: 4.14
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.71Np Likeness Score: -1.48

References

1. Fortin S, Charest-Morin X, Turcotte V, Lauvaux C, Lacroix J, Côté MF, Gobeil S, C-Gaudreault R..  (2017)  Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells.,  60  (12): [PMID:28535350] [10.1021/acs.jmedchem.7b00343]

Source